Dr. Mark Ogunsusi is an associate in the drug pricing and 340B program practice group of Powers Pyles Sutter & Verville. He focuses his practice primarily on regulatory matters involving pharmaceutical pricing and, specifically, the 340B federal drug discount program. In addition to his legal degree, he holds a Doctor of Pharmacy degree. Dr. Ogunsusi regularly advises an array of health care entities on the nuances of the 340B program, the Medicaid drug rebate program, federal pharmacy law, food and drug law, and state pharmacy law. He has significant experience in all aspects of the 340B program, including covered entity registrations, contract pharmacy arrangements, patient eligibility determinations, duplicate discount issues, drug inventory management, eligibility requirements, third party vendor arrangements, auditable records requirements, and other program compliance matters.